WHO infant malaria drug approval 2026

WHO Infant Malaria Drug Approval 2026: First-Ever Treatment for Newborns Announced by WHO on World Malaria Day

WHO infant malaria drug approval 2026 marks a historic breakthrough as the World Health Organization approves the first-ever malaria treatment specifically designed for newborns and infants, improving global child health and malaria control efforts. WHO Approves First-Ever Infant-Specific Malaria Drug on World Malaria Day 2026 🧪 WHO’s Historic Approval of Infant-Specific Malaria Drug The World…

Read Full News
malaria medicine for infants

Malaria Medicine for Infants Approved: Coartem Baby Gets Swissmedic Nod for Newborn Treatment

Malaria medicine for infants approved by Swissmedic! Coartem Baby becomes the first antimalarial drug for newborns, targeting babies weighing 2–5 kg. Essential update for government exam aspirants. 🌍 Switzerland Clears First Malaria Medicine for Small Babies Overview of the Breakthrough On July 9, 2025, Swissmedic, Switzerland’s medical regulatory authority, granted approval for Coartem Baby (also…

Read Full News
"Maternal RSV Vaccine"

Pfizer’s Maternal RSV Vaccine: A Breakthrough for Infant Health

US FDA Approves Pfizer’s Maternal RSV Vaccine to Protect Infants The US Food and Drug Administration (FDA) has recently granted approval to Pfizer’s Maternal Respiratory Syncytial Virus (RSV) Vaccine, marking a significant development in maternal and infant healthcare. This groundbreaking vaccine is designed to safeguard infants against the potentially severe and sometimes life-threatening effects of…

Read Full News